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ABSTRACT  42 
Nasopharyngeal colonization is important for Streptococcus pneumoniae evolution, providing 43 
the opportunity for horizontal gene transfer when multiple strains co-occur. Although 44 
colonization with more than one strain of pneumococcus is common, the factors that influence 45 
the ability of strains to co-exist are not known.  A highly variable blp (bacteriocin-like peptide) 46 
locus has been identified in all sequenced strains of S. pneumoniae. This locus controls the 47 
regulation and secretion of bacteriocins, small peptides that target other bacteria. In this study, 48 
we analyzed a series of co-colonizing isolates to evaluate the impact of the blp locus on human 49 
colonization to determine whether competitive phenotypes of bacteriocin secretion restrict co-50 
colonization. 51 
 52 
We identified a collection of 135 nasopharyngeal samples with two or more strains totaling 285 53 
isolates. The blp locus of all strains was characterized genetically with regards to pheromone 54 
type, bacteriocin/immunity content and potential for locus functionality. Inhibitory phenotypes 55 
of bacteriocin secretion and locus activity were assessed through overlay assays. Isolates from 56 
single colonization (n=298) were characterized for comparison.  57 
 58 
Co-colonizing strains had a high diversity of blp cassettes; approximately one third displayed an 59 
inhibitory phenotype in vitro. Despite in vitro evidence of competition, pneumococci co-60 
colonized individuals independently of their blp pheromone type (p=0.577), 61 
bacteriocin/immunity content, blp locus activity (p=0.798) and inhibitory phenotype (p=0.716). 62 
 o
n
 June 22, 2016 by ST G
EO
RG
E'S LIBRARY
http://aem
.asm
.org/
D
ow
nloaded from
 
4 
 
In addition, no significant differences were observed when single and co-colonizing strains were 63 
compared. 64 
 65 
Despite clear evidence of blp-mediated competition in experimental models, our study suggests 66 
that the blp locus plays a limited role in restricting pneumococcal co-colonization in humans. 67 
 68 
IMPORTANCE  69 
Nasopharyngeal colonization with Streptococcus pneumoniae (pneumococcus) is important for 70 
pneumococcal evolution as it represents the major site for horizontal gene transfer when 71 
multiple strains co-occur, a phenomenon known as co-colonization. Understanding how 72 
pneumococcal strains interact within the competitive environment of the nasopharynx is of 73 
chief importance in the context of pneumococcal ecology. In this study we used an unbiased 74 
collection of naturally co-occurring pneumococcal strains and showed that a biological process 75 
frequently used by bacteria for competition – bacteriocin production - is not decisive in the co-76 
existence of pneumococci in the host, contrary to what has been shown in experimental 77 
models. 78 
 79 
INTRODUCTION 80 
Streptococcus pneumoniae is an important bacterial pathogen associated with high morbidity 81 
and mortality worldwide (1-3). Notwithstanding, disease is a rare event compared with the 82 
frequency of asymptomatic nasopharyngeal colonization (4). 83 
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 84 
Nasopharyngeal colonization is particularly frequent among young children (5) and multiple 85 
strains can be simultaneously detected in the same sample (6-8). As pneumococcus is naturally 86 
competent and known to evolve mainly through genetic recombination (9), co-colonization is 87 
fundamental for its evolution (10, 11). Donker et al correlated the extensive recombination 88 
among pediatric colonization strains with a high prevalence of co-colonization in that 89 
population, highlighting the importance of having a better understanding of this phenomenon.  90 
 91 
Little is known about how pneumococcal strains interact with each other within the 92 
nasopharynx. Data from longitudinal studies have shown that the pneumococcal population 93 
colonizing children is in constant turnover (5, 12). Although over 95 serotypes have been 94 
described to date in the pneumococcal population (13, 14), only a small subset are dominant in 95 
carriage suggesting a higher competitive ability of these serotypes (15, 16). The fact that the 96 
pneumococcus’ natural niche is a dense polymicrobial environment with limited resources also 97 
suggests that competitive interactions are important in its lifestyle (17). 98 
 99 
To date, two main molecular mechanisms have been implicated in pneumococcal intra-species 100 
competition: competence-mediated fratricide and bacteriocin production (18-21). These 101 
systems were historically thought of as independent. However, recent work has demonstrated 102 
that they are coordinately regulated suggesting that, under some circumstances, fratricide and 103 
bacteriocin production may work in concert to target neighboring cells (22, 23). 104 
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 105 
Fratricide is used by competent cells not only to eliminate direct competitors, but also to obtain 106 
nutrients and DNA released by non-competent lysed cells (19). Because pneumococcal 107 
populations are divided into two pherotypes that express and respond to distinct competence 108 
stimulating peptide (CSP) types, it was originally hypothesized that CSP might influence co-109 
colonization as a result of fratricide-mediated exclusion. Two studies that evaluated the impact 110 
of CSP pherotype on the co-existence of pneumococci in humans could not confirm this 111 
hypothesis (24, 25).  112 
 113 
In S. pneumoniae, the blp locus (associated with bacteriocin production) has been shown to play 114 
a role in intraspecies competition in a murine model of co-colonization (20). The blp locus 115 
encodes the factors required for the regulation, production and secretion of bacteriocins and 116 
their associated immunity proteins. The locus is controlled by a two component regulatory 117 
system consisting of a histidine kinase (BlpH) and a response regulator (BlpR). The system is 118 
activated when the signalling peptide, BlpC, binds to its cognate BlpH receptor (20, 21) resulting 119 
in phosphorylation and activation of the regulator, BlpR. BlpR activation results in upregulation 120 
of the entire blp locus (26) including the bacteriocin/immunity region (BIR) that encodes the 121 
bacteriocins and their cognate co-transcribed immunity proteins (27, 28). Bacteriocins (and 122 
BlpC) are primarily secreted by the ABC transporter BlpAB (20-23, 26). 123 
 124 
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The blp locus is highly diverse. There is significant variability in the BIR, at least sixteen 125 
bacteriocin peptides have been described, several with allelic variability and strains can vary 126 
with respect to the number of encoded bacteriocins (27, 28). Also, at least five types of the 127 
peptide pheromone BlpC have been found (21, 26-28). In addition, a significant fraction of 128 
pneumococcal strains carry a disruption in the genes encoding the BlpAB transporter (27). These 129 
strains can respond to exogenous pheromone with the production of immunity proteins but 130 
cannot secrete bacteriocins. The prevalence of these strains suggests that strategies that limit 131 
locus stimulation and peptide secretion may provide an energetic advantage. It was recently 132 
shown that blpAB disrupted strains can secrete a fraction of the blp pheromone, BlpC, through 133 
the homologous competence transporter, ComAB, allowing for self-stimulation of the locus (22, 134 
23).  This secretion only occurs during the competent state when sufficient ComAB is produced 135 
to support BlpC secretion and is enhanced by cross stimulation of some of the blp promoters by 136 
the competence response regulator, ComE. The universal presence of the blp locus in 137 
pneumococci and the significant diversity of its content suggest that this locus provides a 138 
competitive advantage either during colonization or transmission (28). No studies to date have 139 
used colonizing isolates from humans to examine whether blp locus activity is sufficiently 140 
widespread to restrict the strains that can co-exist within the nasopharynx.  141 
 142 
In this study we explored the role of the blp locus and bacteriocin secretion on the co-existence 143 
of S. pneumoniae in human nasopharyngeal samples.  144 
 145 
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METHODS 146 
Sample selection and isolation of pneumococci 147 
Nasopharyngeal samples collected from healthy children attending day-care centers in Oeiras 148 
and Montemor-o-Novo, Portugal, were retrospectively selected from cross-sectional studies 149 
conducted in 2001, 2006, 2007, 2009, and 2010 (29-32). In those studies, samples were 150 
routinely plated in selective media for S. pneumoniae (5% blood trypticase soy agar containing 151 
5mg/L gentamicin) and incubated overnight at 37⁰C under anaerobic conditions with an 152 
optochin disk. On the second day, pneumococcal colonies with different morphologies were 153 
picked and plated separately, one colony per morphology. In the majority of the cases (>90%) 154 
only one morphology was detected with naked eye. The bacterial lawn of the primary selective 155 
plate, herein called “primary sample”, was collected and frozen at -80⁰C in 1mL Mueller-Hinton 156 
broth with 30% glycerol. On the third day, pneumococcal pure cultures were also frozen.  157 
 158 
Pneumococcal strains were serotyped by multiplex PCR as described previously (33, 34), 159 
[http://www.cdc.gov/streplab/pcr.html], or by the Quellung reaction, as appropriate 160 
(35)(Statens Serum Institute, Copenhagen, Denmark).  161 
 162 
To maximize the likelihood of detecting significant associations between serotypes in multiple 163 
carriage events, and given the high serotype diversity of pneumococci, we first identified all 164 
samples containing pneumococci. Then, based on our previous observation that the serotypes 165 
more frequently found in single and multiple carriage events are essentially the same (36), we 166 
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identified the serotypes with highest cumulative prevalence in the cross-sectional studies 167 
described above. These were: 3, 6A, 6C, 11A, 15A, 15B/C, 19A, 19F, 21, 23A, 23B and non-168 
encapsulated pneumococci (NT). In total, 1,415 samples were identified and selected for 169 
molecular detection of co-colonization. Of these, 66.2% (936/1,415) were collected from 170 
children vaccinated with at least one dose of either the 7- or the 10-valent pneumococcal 171 
conjugate vaccine, 30.7% (435/1,415) were collected from non-vaccinated children, and 3.1% 172 
(44/1,415) were collected from children from whom the vaccination status was unknown.  173 
 174 
DNA isolation 175 
Total DNA was isolated from 200µL of the primary sample frozen stock using the High Pure PCR 176 
Template Preparation Kit (Roche Diagnostics, Mannheim, Germany) according to the 177 
manufacturer’s instructions.  178 
 179 
Detection of co-colonization and capsular typing of the co-colonizing strains 180 
Detection of co-colonization was done using the plyNCR-RFLP (37) and the BuG@S SP-CPSv1.4.0 181 
microarray for molecular serotyping as previously described (36). 182 
 183 
All serotypes identified by the microarray were confirmed by PCR using as template purified 184 
DNA of the primary sample. 185 
 186 
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For the interpretation of the microarray results, a serotype was considered a major serotype 187 
whenever its relative abundance was ≥70%. Accordingly, a serotype was considered a minor 188 
serotype whenever its relative abundance was ≤30%. Serotypes with relative abundances > 30% 189 
and <70% were considered co-dominant. 190 
 191 
Isolation of pneumococcal strains from the co-colonized samples 192 
Aliquots of the primary sample frozen stock were prepared, serially diluted and plated in 5% 193 
blood trypticase soy agar containing 5mg/L gentamicin plates to obtain isolated colonies. 194 
Individual colonies were picked for amplification of serotype-specific capsular genes. The 195 
number of colonies picked was calculated as described by Huebner et al. (38). One colony of 196 
each capsular type was subcultured and frozen. For isolation and correct identification of non-197 
encapsulated pneumococci the method described by Simões et al. was used (39).  198 
 199 
MLST  200 
Multilocus sequence typing was done as described previously (40). Novel STs and the 201 
corresponding strain information were deposited at the public MLST database for S. 202 
pneumoniae (http://pubmlst.org/spneumoniae/). 203 
 204 
Assignment of pherotype CSP1 or CSP2 205 
Pherotype assignment was done by multiplex PCR amplification of specific comC gene 206 
fragments, as described previously (41).  207 
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 208 
PCR assignment of blpC type 209 
Assignment of the five blpC types described up to now was done by amplification of specific 210 
blpC gene fragments, using primers designed for this study (Table S1). The PCR reactions varied 211 
according to primer pair, as described in Table S1.  212 
 213 
Overlay assays 214 
Inhibition and activity overlay assays were performed as described elsewhere (27) and using the 215 
reporter strains listed in Table 1.  216 
 217 
Assessment of blpA integrity 218 
Detection of the 4 bp repeat insertion was done by PCR amplification of a blpA gene fragment 219 
containing the region of repeat insertion using forward primer 21 described in (27) and reverse 220 
primer with sequence AGCCGCTGATGAAATGGGC, followed by digestion with Cac8I (New 221 
England Biolabs, Ipswich, MA, USA), according to the manufacturer’s instructions. Restriction 222 
occurs only when the 4 bp repeat is present. 223 
 224 
Samples in which we failed to amplify the region containing the repeat insertion were amplified 225 
with primers 18 and 19 described in (27) for amplification of the total blpA gene to confirm 226 
presence of possible deletions by comparison of the size of the PCR product with that of a 227 
control strain with an intact blpA gene. 228 
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 229 
RFLP analysis of the bacteriocin/immunity region (BIR) and bacteriocin content prediction 230 
RFLP profiles of all isolates were determined as previously described (27). Briefly, PCR products 231 
were obtained with primers 1 and 2, purified and digested with AseI (New England Biolabs, 232 
Ipswich, MA, USA), according to the manufacturer’s instructions. Digestion products were 233 
analyzed by capillary electrophoresis and isolates with identical restriction patterns were 234 
assigned to the same group.  235 
 236 
BIR content was predicted by comparison of RFLP profiles with those of sequenced strains 237 
available at GenBank, using either VectorNTI or CLC Genomics softwares. Overlay assays with 238 
reporter strains of known BIR contents (Table 1) were performed as a control for in silico 239 
predictions. 240 
 241 
Data analysis 242 
The frequencies of several trait types (serotypes, genotype, CSP, BlpC, BlpA and inhibitory 243 
activity) were compared between co-colonization and single colonization samples (sample 244 
types). To detect statistically significant differences, 5000 random datasets were generated by 245 
randomly permuting the strain’s trait and sample types. Two tailed p-values were computed by 246 
comparing individual frequencies of each trait type in each sample type to permutation-derived 247 
frequencies. The deviation of the complete trait/sample types distribution from the null 248 
hypothesis was evaluated through a Fisher’s Exact Test. A similar analysis was performed to 249 
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compare strains classified as minor, co-dominant or major, according to their relative 250 
abundance.  251 
 252 
The frequency with which pairs of serotypes (or of genotypes, CSP, BlpC and BlpA types) appear 253 
together in co-colonizing samples was also compared with a null hypothesis where strains mix 254 
randomly. The null distribution was estimated through 5000 random assignments of strains to 255 
the samples with co-colonization events. Each sample had to contain at least one strain from 256 
the set of serotypes used to select the samples included in this study (3, 6A, 6C, 11A/D, 15A, 257 
15B/C, 19A, 19F, 21, 23A, 23B, NT). A similar analysis was performed to compare the pair type 258 
frequency among samples with major/minor versus co-dominant co-colonization events. 259 
 260 
Frequency deviations were considered significant when p-values<0.05. 261 
 262 
RESULTS 263 
S. pneumoniae strains co-colonizing individuals are highly diverse and co-exist independently 264 
of the capsular type and genotype 265 
Out of the 1,415 samples included in the study to screen for pneumococcal co-colonization, 285 266 
pneumococcal strains were isolated from 135 co-colonized samples (Figure 1). Strains were 267 
found to be highly diverse: 36 capsular types were found and MLST genotyping clustered strains 268 
in 19 clonal complexes (CC, CC1-CC19) and 36 singletons (S, S1-S36) (Figure 2). MLST analysis 269 
revealed 24 novel STs, 10 of which were originated by the presence of new alleles (STs 9146, 270 
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9147, 9148, 9149, 9150, 9151, 9722, 9724, 9725, and 9726) and 14 resulted from novel allele 271 
combinations (STs 9152, 9153, 9154, 9155, 9156, 9157, 9158, 9159, 9160, 9161, 9162, 9163, 272 
9164, and 9720). Among the latter, for three STs (ST9160, ST9162 and ST9164) the allele 273 
separating the novel ST from its SLV was shared with its co-colonizing strain, suggesting that 274 
within host recombination might have occurred with the co-colonizing strain (Table 2). 275 
 276 
Positive associations were found between some serotypes and sequence types in this collection, 277 
although these correlations are of unclear significance.  Statistically significant correlations are 278 
listed in Table S2. 279 
 280 
CSP assignment of all strains showed that 35.2% of the interactions occurring in the 135 co-281 
colonized samples were between two strains of CSP1, 10.9% were between two strains of CSP2, 282 
and 51.5% were between strains of different pherotypes (CSP1, CSP2, and other type present in 283 
strains from serotype 38). When the frequency in which CSP types appear together in co-284 
colonization was compared with the frequency estimated under the hypothesis that strains mix 285 
randomly, the results suggested a tendency for co-colonization with strains of different CSP 286 
types, although with low robustness (p=0.048).  287 
 288 
Despite some positive associations found at the serotype and genotype levels, the large 289 
diversity of our collection seems to suggest that pneumococcal strains co-colonize the human 290 
nasopharynx independently of their capsule, genetic background and CSP type. 291 
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 292 
Genetic characterization of the blp locus of co-colonizing pneumococci reveals high diversity 293 
of blp cassettes  294 
The genetic characterization of the blp locus of the co-colonizing strains was focused on the 295 
RFLP analysis of the BIR, on the assignment of the blpC type and on the assessment of blpA 296 
integrity. The results are summarized in Figure 2. 297 
 298 
Thirty-nine BIR RFLP profiles were identified, from which 16 could be assigned to known BIR 299 
sequences available in GenBank and accounted for 70.9% (n=202/285) of the strains. The 300 
remaining 23 profiles corresponded to not yet described BIR regions and accounted for 25.6% 301 
(n=73/285) of the strains. In ten strains (3.5%, 10/285) we were not able to amplify the BIR 302 
region, despite several attempts. Of note, some BIR profiles, such as profiles 7 and 11, were 303 
detected in several clonal complexes (CC). Other profiles, highly prevalent as well, were 304 
restricted to a single CC, such as profiles 10 and 8, associated with CC5 and CC2, respectively. 305 
Our BIR predictions indicated that the number of bacteriocin peptides present in the co-306 
colonizing strains varied between 2 and 6. Interestingly, profiles predicted to contain the highest 307 
number of bacteriocin peptides (profiles 7 and 11) were associated mostly with strains with a 308 
disrupted blpA (described below). 309 
 310 
High prevalence of strains with disrupted blpA gene co-colonizing in nature 311 
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Disruption of the blpA transporter gene has been previously associated with a cheater 312 
phenotype, i.e., non-inhibitory immune-only (27). Analysis of the blpA gene showed a disruption 313 
in the gene in 155 out of 285 strains (54.4%). Of these, 151 strains contained the 4 bp repeat 314 
insertion described by Son et al. (27) and four strains had a larger deletion of approximately 840 315 
bp.  316 
 317 
In the sets of co-colonized samples, 27.9% of dual interactions occurred between two cheater 318 
strains, 20.6% between strains with intact blpA genes (non-cheaters), and 51.5% occurred 319 
between a cheater and a non-cheater strain. Comparison of the estimated and observed 320 
proportions of events involving strains with same or different blpA status (intact or disrupted) 321 
did not show a significant difference, suggesting that the cheater phenotype alone does not 322 
restrict co-colonization of pneumococci (p=0.713). 323 
 324 
Pheromone peptides BlpC are not equally distributed in the population and do not restrict co-325 
colonization 326 
Co-existence of strains secreting different BlpC peptides implies that the strain at higher cell 327 
density would activate its blp locus earlier and be at a competitive advantage. To assess if the 328 
type of BlpC could prevent or facilitate co-existence of pneumococci in the host we determined 329 
the blpC allelle of the 285 co-colonizing strains. The results showed that 36.8% of the strains 330 
were of type blpCT4, 22.5% of type blpCP164, 22.1% of type blpC6A, 16.5% of type blpCR6, and 2.1% 331 
 o
n
 June 22, 2016 by ST G
EO
RG
E'S LIBRARY
http://aem
.asm
.org/
D
ow
nloaded from
 
17 
 
of type blpCP155. Of note, this latter blpC type was associated exclusively with non-encapsulated 332 
pneumococci.  333 
 334 
To evaluate the ability of the strains to activate their own locus, signaling overlay assays were 335 
performed for all strains using BlpC-specific reporter strains for each BlpC of the four major 336 
types (Table 1). The BlpC type was confirmed in all strains in which it was possible to observe 337 
locus activity, as indicated by the β-galactosidase activity in the assays (n=59). However, for 338 
most strains (79%, n=226/285) we were not able to confirm phenotypically the secretion of the 339 
encoded BlpC type. This could be largely explained by the fact that 69% (n=155/226) of the non-340 
inducible strains were in fact cheaters. blpA disruption was mainly associated with strains of 341 
type blpCR6 and blpCT4 (p=0.0001 for both, Fisher’s exact test) (Figure 3). In the remaining 71 342 
strains a blpA disruption was not detected. A likely explanation for the lack of BlpC secretion in 343 
these strains would be the presence of non-repeat mutations in blpA, or mutations in blpB, blpH 344 
or blpR, a blpC/blpH mismatch, or mutations in the promotor regions of blpABC or blpRH, all of 345 
which have been described in other collections (22, 27, 45). 346 
 347 
Looking at the sets of co-colonization samples, 40.6% of the dual interactions were between 348 
strains of the same BlpC type, while 59.4% were between strains of different BlpC types. When 349 
the frequency in which BlpC types appear together in co-colonization was compared with the 350 
frequency estimated under the hypothesis that strains mix randomly no significant difference 351 
was found (p=0.577). The same analysis was performed considering only pairs of strains in 352 
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which secretion of BlpC was confirmed phenotypically through overlay assays in one of the 353 
strains; no significant difference was found as well (p=0.798). 354 
 355 
Phenotypes of bacteriocin secretion do not restrict co-colonization 356 
To determine the phenotype of bacteriocin secretion, i.e., the inhibitory activity of the 357 
pneumococcal strains, overlay assays with a susceptible reporter pneumococcal strain P537 358 
(Δblp) were performed. 359 
 360 
Eighty-four out of 285 (29.5%) co-colonizing strains displayed inhibitory activity against P537. Of 361 
these, 21 strains (25%) had a disrupted blpA gene and no evidence of pheromone secretion 362 
using reporter strains (suggesting a non-blp mediated inhibition) and 63 strains had an intact 363 
blpA gene. Among the latter, 53 strains were in the group in which BlpC pheromone secretion 364 
was observed in the signaling overlays. For the other 10, the signaling overlay assay had been 365 
negative.  366 
 367 
Among the strains that did not display inhibitory activity (n=201), 67% were cheaters and 30% 368 
did not secrete pheromone in the signaling overlays, despite an apparently intact blpA gene.  369 
 370 
In the sets of co-colonized samples, co-existence of strains that displayed an inhibitory 371 
phenotype was not different from what would be expected by chance, suggesting that an 372 
inhibitory phenotype alone does not prevent co-colonization (p=0.715). 373 
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 374 
Considering this result, we performed an in silico prediction of the outcome of the interaction of 375 
each pair of strains in every sample, taking into account the genetic content of the BIR, the 376 
integrity of the blpA transporter gene and the type of signaling peptide BlpC secreted. Our 377 
prediction resulted in 50 outcomes of inhibition (30.3%) and 115 outcomes of no inhibition 378 
(69.7%). Comparison of the estimated and predicted proportions of outcomes of inhibition and 379 
no inhibition did not show a significant difference (p=0.274).  380 
 381 
The results obtained with the genotypic and phenotypic approaches suggest that the blp locus 382 
alone does not seem to prevent the co-existence of pneumococci in the host. 383 
 384 
Phenotypes of bacteriocin secretion are the same in strains isolated from single and co-385 
colonization events 386 
In order to assess whether strains found in single and co-colonization events would display 387 
different genotypic and/or phenotypic blp characteristics, we selected a subset (n=298) of the 388 
initial 1,053 nasopharyngeal samples in which only one strain was detected, for comparison 389 
with the collection of co-colonized samples. This selection was performed randomly but 390 
maintaining a matched number of samples from each year between both collections. The 391 
characteristics of this collection are summarized in Table S3.  392 
 393 
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Overall, the prevalence of each blpC type was similar in the two collections, as well as the 394 
distribution of inducible, non-inducible and cheater strains within each blpC type (Figures 3 and 395 
4A). Similarly, no significant differences were observed in the two collections regarding the 396 
proportion of strains with an inhibitory phenotype, cheaters, and an active locus (Figure 4B). 397 
 398 
DISCUSSION 399 
Bacteriocin production is a common trait in organisms that reside in polymicrobial communities. 400 
Bacteriocin mediated competition has been shown to alter the composition of the microbiota in 401 
environmental communities and on human surfaces (46). 402 
 403 
Animal models of pneumococcal colonization have demonstrated that bacteriocin production 404 
provides a competitive advantage during establishment on the mucosal surface (20, 27). These 405 
experiments were performed by inoculating mixtures of competing strains at a 1:1 ratio 406 
simultaneously into the nasopharynx of a mouse. Colonization dynamics in humans is likely to 407 
be far more complex than the experimental conditions used in these studies. Although co-408 
colonization with distinct pneumococcal strains is quite common, the relative proximity of these 409 
strains within the human host is not known. What is clear, based on extensive genome studies, 410 
is that organisms are in close enough proximity to support genetic exchange (9, 47). In this 411 
study, we used a collection of co-colonizing and single colonizing isolates that reflect true 412 
colonization patterns in the human host to better understand the contribution of bacteriocin 413 
production to global colonization dynamics. 414 
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 415 
Characterization of the co-colonization strains at the level of serotype and genotype enabled us 416 
to investigate positive associations between specific capsular types and genotypes, although no 417 
straightforward observations could be found to explain those associations. At the capsular level, 418 
we explored properties shown to be dependent on the capsular type, such as the 419 
polysaccharide structure, and, by association, the fitness cost of capsule production (48, 49), 420 
and the surface charge of the capsular type (50). All these properties have been shown to 421 
predict the prevalence of the serotypes (48, 49). Interestingly, Trzciński et al. (51) have shown a 422 
reproducible hierarchy of capsular types in a mouse model of multiple serotype carriage, which 423 
correlated with the metabolic cost and the surface charge measured in vitro. Our prevalence 424 
results are in agreement with the proposed hypothesis but none of the explored properties 425 
could explain the serotype associations identified in this study. This may have been due to the 426 
fact that interactions in the human host are likely to be far more complex than in experimental 427 
systems. 428 
 429 
The genetic characterization of the blp locus of the co-colonizing strains allowed us to show a 430 
very large diversity in this locus, originated from the diversity in the blpC, blpA and BIR region, 431 
supporting observations from other studies (20, 26-28, 52). Notwithstanding, MLST genotyping 432 
of the strains enabled us to show a fairly high level of conservation of the blp locus among 433 
closely-related strains, suggesting that this extensive genetic diversification is occurring at a rate 434 
sufficiently low for some clonality to be sustained. 435 
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 436 
Overall our genotypic and phenotypic characterization of the blp locus of co-colonizing 437 
pneumococci seems to suggest that the phenotypes of bacteriocin secretion do not have an 438 
impact in the co-existence of pneumococci in the nasopharynx, an observation that was 439 
supported by the lack of differences in the results obtained in the characterization of the single 440 
carriage isolates. Given the large diversity in this locus, it is not surprising that the effect of blp-441 
mediated competition on co-colonization is not as straightforward as might be expected and 442 
several aspects must be taken into account.  443 
 444 
First, the high diversity of BlpH receptors due to the existence of naturally occurring chimeras 445 
for the blpH6A gene, as described by Pinchas et al. (43), may affect the likelihood of cross 446 
stimulation between co-colonizing pairs. These authors have shown that these BlpH variants 447 
have different specificities for cognate and non-cognate BlpC peptides, which can affect the 448 
outcome of neighboring blp locus activation.  449 
 450 
Second, the large array of bacteriocins and immunity proteins that can be present in a strain, 451 
and the fact that the pneumococcal natural niche is a polymicrobial environment, raises the 452 
hypothesis that this competition mechanism might be used for mediating the interaction not 453 
only with bacteria from the same species, but also with other inhabitants of the nasopharynx. In 454 
fact, Lux et al. (52) have demonstrated the inhibitory activity of pneumococci against bacteria of 455 
different species.  456 
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 457 
Finally, the natural and highly frequent occurrence of strains that display a cheater phenotype 458 
also contributes to the complexity of this competition mechanism. The reason why these 459 
cheater strains are so highly prevalent remains to be addressed and the advantage of displaying 460 
this phenotype is not completely clear. On one hand, these strains avoid the fitness-cost of 461 
bacteriocin secretion while they are still able to express immunity proteins. On the other hand, 462 
they become at risk of elimination upon the encounter of a strain secreting a different BlpC 463 
type. Two recent publications (22, 23) have demonstrated a regulatory connection between the 464 
com system, controlling competence and the blp system. These studies demonstrated that BlpC 465 
could be secreted by the competence regulated transporter, ComAB under competence 466 
inducing conditions. ComAB secreted BlpC could then stimulate the blp locus through the BlpHR 467 
regulatory mechanism. None of these studies has, however, shown the ability of these strains to 468 
use ComAB as a bacteriocin secretion system, suggesting that the previously named “cheater” 469 
strains may be able to self-activate the locus during competence but have the capability to 470 
display only an immune phenotype. We have performed signalling overlays in close to 600 471 
strains, from which over half had a disrupted blpA gene, and we were never able to see locus 472 
activation in a strain with blpA disruption. Nevertheless, as the conditions of our assays do not 473 
control for competence activation, we have repeated the analysis performed in this study 474 
considering that all strains would be able to activate the blp locus and express immunity and the 475 
conclusion that bacteriocin secretion does not restrict co-colonization was maintained: 476 
predictions resulted in 95 outcomes of inhibition, 51 outcomes of no inhibition and 19 events in 477 
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which it was not possible to predict an outcome due to unknown bacteriocin/immunity contents 478 
in the strains (p=0.628, Fisher’s exact test). 479 
 480 
Our study has some limitations. First, we did not sequence the entire BIR locus, which might 481 
have helped in explaining the lack of BlpC secretion in the 71 strains with an apparently intact 482 
blpA. Lack of BlpC secretion may have been due to mutations in blpA, blpB, blpH or blpR (22, 27, 483 
45). In fact, looking at over 4,000 pneumococcal genomes, Kjos et al. (22) have shown that only 484 
23% of the genomes had intact blpAB genes, which is in agreement with the 21% proportion of 485 
secretor strains that we have obtained with the signaling overlays. Yet other alternative 486 
explanations could be a blpC/blpH mismatch in these strains (43), lack of sensitivity of the assay, 487 
or the requirement of particular conditions for locus activation in those strains. In addition, the 488 
few non-inhibitory strains with intact pheromone secretion may have harbored mutations in 489 
their bacteriocin genes that would not be detected with the RFLP analysis. Second, we did not 490 
determine the opaque/transparent phenotype of our strains, which might have helped to 491 
explain the lack of inhibitory activity in the 69 intact strains that failed to inhibit the susceptible 492 
strain. Dawid et al (53) have shown that opaque and transparent variants of a strain with an 493 
intact blpA gene had different inhibitory profiles, despite the fact that the amount of blpMNPO 494 
transcripts was the same. These differences were attributed to different expression levels of the 495 
HtrA protease. In particular, in opaque variants expression of HtrA was higher resulting in 496 
degradation of BlpC and hence in decreased bacteriocin secretion (42). Still, this link between 497 
opacity variants and HtrA expression was shown for a single 6A strain only and it is unknown 498 
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whether this is a general property of pneumococcal strains. Third, the cross-sectional nature of 499 
our study prevented us from measuring the effect of blp-mediated competition on the duration 500 
of carriage. Also, we did not measure the pneumococcal load in the samples and it is possible 501 
that the effects of competition might be reflected at the level of carriage density. Even so, we 502 
measured the relative proportion of each strain in the samples and could not establish a 503 
correlation between outcomes of bacteriocin secretion and strain density (Figure S1).  504 
 505 
Our study has also significant strengths. We have used a very well characterized, natural 506 
collection of co- and singly colonized samples identified through the use of highly sensitive 507 
molecular methods. This enabled us to obtain an unbiased and highly diverse collection of both 508 
single and co-colonizing pneumococcal strains to measure the impact of blp-bacteriocin 509 
production on competition in the nasopharynx.  510 
 511 
Our results demonstrate the importance of using human samples to support conclusions drawn 512 
using idealized animal models and are likely to have implications for other bacteriocin systems 513 
that have been exclusively studied in animal models. For example, similar to the case with the 514 
blp bacteriocins, studies performed in animal models have shown that bacteriocin secretion is 515 
important in Streptococcus mutans competition in early dental biofilms (54) and in the ability of 516 
Enterococcus faecalis to colonize of the mammalian gut (55). In light of our study, it would be of 517 
interest to determine if the expected correlations hold true when natural samples from the 518 
human host are studied.  519 
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 520 
Although we have not seen an effect of blp-mediated competition on co-colonization, the fact 521 
that this locus is present in all pneumococci and has been maintained by evolution (28) suggests 522 
an important function, which is supported by the results obtained in competition experiments 523 
showing that the locus is active in vivo (20). The link between the blp and com systems suggests 524 
that the blp locus could be important to increase the DNA pool for transformation (22, 23). Also, 525 
it could be important under specific conditions (e.g., nutrient limitation) or during the 526 
establishment of a strain during colonization by creating an isolated niche. Moreover, studies 527 
with a longitudinal design would help to determine whether blp-mediated competition might be 528 
acting at the level of carriage duration or density.  529 
 530 
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FIGURE LEGENDS 702 
Figure 1. Strategy used for identification of co-colonized samples and isolation of co-colonizing 703 
pneumococcal strains. 704 
 705 
Figure 2. Genetic diversity and characteristics of the blp locus of co-colonizing pneumococci. 706 
Interpretation of results was performed using the goeBURST algorithm to determine possible 707 
evolutionary relationships between isolates: strains sharing 5 out of 7 alleles were considered 708 
genetically related. Clonal complexes (CC) were assigned considering only the collection of co-709 
colonizing pneumococci. Each circle represents a sequence type (ST). The size of the circle is 710 
proportional to the number of isolates of that ST. The serotype(s) of the isolates belonging to a 711 
given ST is indicated inside each circle. Related ST are grouped in clonal complexes (CC, Panel A) 712 
and unrelated ST are represented as singletons (S, Panel B). For each ST information on CSP type 713 
and genetic characterization of blp locus is represented by the bars; the first section represents 714 
CSP type (CSP1 in black, CSP2 in light gray, other type in dark gray); the second section 715 
represents blpC type (dark green for blpCP164, light green for blpCR6, dark blue for blpC6A, light 716 
blue for blpCT4, and pink for blpCP155); the third section represents presence (red cross) or 717 
absence (white) of disruption in blpA; the fourth section represents the BIR profile, numbered 1 718 
to 39.  BIR RFLP profiles matched to genome sequenced strains (GenBank designations): 1 719 
(GA13723), 2 (AP200), 3 (GA13856), 4 (GA54354), 5 (20703335), 7 (GA47439), 9 (670-6B), 10 720 
(OXO141), 11 (GA17971), 12 (CDC1087), 14 (46518), 18 (SP14-BS69), 19 (GA47502), 20 (70585), 721 
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21 (8a-SA64), and 22 (5a-14-3). ND, BIR profiles not determined due to failure to amplify the BIR 722 
region. 723 
 724 
Figure 3. Distribution of blpC types in the co-colonization strains. Asterisks indicate statistically 725 
significant differences. Black, active secretion; dark gray, no secretion, cheaters; white, no 726 
secretion, putative non cheaters; light gray, not tested for active secretion, putative non 727 
cheaters. Error bars represent standard error. 728 
 729 
Figure 4. Characterization of the blp locus of the strains isolated from single carriage events. 730 
(A) Distribution of blpC types in the co-colonization strains. Asterisk indicates statistically 731 
significant differences. Black, active secretion; dark gray, no secretion, cheaters; white, no 732 
secretion, putative non cheaters; light gray, not tested for active secretion, putative non 733 
cheaters. Error bars represent standard error. (B) Comparison of the single and co-colonized 734 
collections regarding proportions of strains with inhibitory phenotype, cheater genotype and 735 
locus inducibility. Dark gray, co-colonization strains; white, single carriage strains. Error bars 736 
represent standard error. 737 
 738 
 739 
 740 
 741 
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Table 1. Reporter and control strains for characterization of the blp locus 
Strain 
designation 
Strain characteristics Reference 
P537 
Serotype 6A strain with deletion of blpRHCBA-
BIR. Susceptible to all bacteriocins secretion.  
Reporter of inhibitory activity 
Son et al., 2011 (27)
PSD121 
R6 background; insertion of a type P164 blp 
locus, with blpC deletion and lac-Z reporter 
under control of the BIR promoter.  
Type P164 BlpC/BlpH reporter 
Kochan et al., 2013 (42) 
PSD101 
R6 background; insertion of a type R6 blp
locus, with blpC deletion and lac-Z reporter 
under control of the BIR promoter.  
Type R6 BlpC/BlpH reporter 
Pinchas et al., 2015 (43)  
PMP105 
R6 background; insertion of a type 6A blp 
locus, with blpC deletion and lac-Z reporter 
under control of the BIR promoter.  
Type 6A BlpC/BlpH reporter 
Pinchas et al., 2015 (43)  
PMP105 
R6 background; insertion of a type T4 blp 
locus, with blpC deletion and lac-Z reporter 
under control of the BIR promoter.  
Pinchas et al., 2015 (43)  
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 Type T4 BlpC/BlpH reporter 
P1 
Serotype 6A, BIR with MNO, BlpC6A.  
Control for MNO BIR content 
Kim et al., 1998 (44)
P4 
Serotype 6B, BIR with QMNO, BlpCP164.  
Control for QMNO BIR content 
Kim et al., 1998 (44)
P132 
Serotype 29, BIR with K, type 3 BlpC6A.    
Control for K BIR content   
Son et al., 2011 (27)
P133 
Serotype 6A, BIR with IJK MNO, BlpCR6.    
Control for IJK MNO BIR content 
Son et al., 2011 (27)
P140 
Serotype 35B, BIR with IJK, BlpCR6.    
Control for IJK BIR content   
Son et al., 2011 (27)
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Table 2. Evidence for putative in vivo horizontal gene transfer among co-colonizing 
strains in nasopharyngeal samples characterized in this study.  
a
 Closest ST found in the MLST database (http://spneumoniae.mlst.net/). NP, 
nasopharyngeal; ST, sequence type. Novel STs and alleles shared with co-colonizing strain 
that generated novel STs represented in bold. In three samples, at least one of the strains 
generated a novel MLST profile not previously described in the MLST database. In all 
cases, the closest match was a single-locus variant. The novel allele was shared with its co-
colonizing strain, suggesting within host recombination. 
NP sample Serotype ST aroE gdh gki recP spi xpt ddl 
Sample 8043          
Strain 1 19A  9160 1 60 9 8 6 3 29 
Strain 2 6C  395 1 5 7 12 17 1 14 
Strain 3 31 1766 1 5 29 1 46 14 18 
Closest ST to strain 1
a
 19A 1151 7 60 9 8 6 3 29 
Sample 8058          
Strain 1 3 9162 2 15 2 10 6 1 22 
Strain 2 23A  9163 2 8 9 9 6 4 6 
Closest ST to strain 1
a
 3 180 7 15 2 10 6 1 22 
Closest ST to strain 2
a
 23A/23F 190 8 8 9 9 6 4 6 
Sample 8098          
Strain 1 6B 9164 7 8 4 18 15 4 31 
Strain 2 3 180 7 15 2 27 2 11 71 
Closest ST to strain 1
a
 6A/6B 5516 2 8 4 18 15 4 31 
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